Clinical Characteristics and Mortality in Community-Acquired Sepsis and Septic Shock Patients in the Intensive Care Unit Setting in Latvia: An Observational Study
Open Access
- 10 September 2025
- journal article
- research article
- Published by MDPI AG in Healthcare
- Vol. 13 (18) , 2264
Abstract
Background: Sepsis and septic shock are medical emergencies with increasing incidence and high intrahospital mortality rates, as they are common causes of admission to the intensive care units (ICU). Early recognition and adequate treatment are important in reducing mortality. Limited data are available on characteristics and outcomes of community-acquired sepsis and septic shock in Latvia. Methods: In this single-center cohort study, we explore clinical characteristics and outcomes of 86 community-acquired sepsis and septic shock cases admitted to the ICU of a clinical university hospital between 2014 and 2018. Results: The ICU and intrahospital mortality rates were 45% and 58%, respectively. Respiratory tract infections, particularly pneumonia and abdominal and skin/soft tissue infections, were the most common sites of origin. Overall, 95% of patients initially received appropriate antibiotic treatment. However, the median time to antibiotics was 225 min (IQR 118–407 min), and only 10% received antimicrobial treatment within 1 h. Conclusions: The number of patients enrolled indicates that sepsis cases are underreported on a national level. The results also demonstrate high mortality rates among ICU patients with community-acquired sepsis and septic shock, compared to other reports. The analysis indicates that early recognition of sepsis signs and organ failure is crucial for improvements in treatment outcomes.Keywords
Funding Information
- Latvijas Zinātnes Padome (lzp-2019/1-0225)
This publication has 30 references indexed in Scilit:
- Enhancing Recovery From SepsisJAMA, 2018
- The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)JAMA, 2016
- Assessment of the worldwide burden of critical illness: the Intensive Care Over Nations (ICON) auditThe Lancet Respiratory Medicine, 2014
- Mortality Related to Severe Sepsis and Septic Shock Among Critically Ill Patients in Australia and New Zealand, 2000-2012JAMA, 2014
- Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012Intensive Care Medicine, 2013
- Effect of Empirical Treatment With Moxifloxacin and Meropenem vs Meropenem on Sepsis-Related Organ Dysfunction in Patients With Severe SepsisJAMA, 2012
- Drotrecogin Alfa (Activated) in Adults with Septic ShockNew England Journal of Medicine, 2012
- Incidence, treatment, and outcome of severe sepsis in ICU-treated adults in Finland: the Finnsepsis studyIntensive Care Medicine, 2007
- The Epidemiology of Sepsis in the United States from 1979 through 2000New England Journal of Medicine, 2003
- Early Goal-Directed Therapy in the Treatment of Severe Sepsis and Septic ShockNew England Journal of Medicine, 2001